National Heart Foundation, Australia   Report issue

Government Phase 3 Phase 4
Founded: Sydney Australia (1959)

Organization Overview

First Clinical Trial
1998
NCT00097669
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

National Heart Foundation, Australia